SyzOnc

What an amazing way to end an incredible program! SyzOnc was so honored to be a part of this inaugural cohort of BrightEdge Entrepreneur (BEE) fellows, and to have the opportunity to showcase our company's journey in Boston yesterday at the BEE pitch event. Our heartfelt thanks to everyone at ACS-BrightEdge who made this exceptional program and event possible. You've always been so supportive of our team and we appreciate you more than you know!

Co-founder Anne Carpenter addressing the future of AI in drug discovery alongside Derek Lowe, Jen Nwankwo, and Alex Snyder. You can hear it in full here: https://lnkd.in/eGpvJ3Md

https://lnkd.in/ehq-NuFJ

I am pleased to announce that the Sarcoma Foundation of America has selected our work for funding in collaboration with UPenn. SFA and SyzOnc are "aligned against cancer" and together will bring SyzOnc's innovation and next generation approaches to patients.

July is Sarcoma Awareness Month. Sarcomas are understudied and patients lack targeted therapeutics. SyzOnc is committed to improving outcomes for sarcoma patients and is proud to partner with the Sarcoma Foundation of America to serve this community. Learn more here! https://lnkd.in/eeE5f8d

SyzOnc is pleased to announce the publication of our landmark study highlighting the critical role of extracellular matrix proteins in regulating the immune microenvironment in solid tumors. https://lnkd.in/effBY8rf

SyzOnc is pleased to announce that co-founder Karin Eisinger, PhD, has taken the helm as SyzOnc’s full time CEO and co-founder Ashley M. Fuller, PhD, has stepped into the role of CSO. We are grateful to our inaugural CEO Tim Considine, JD for taking SyzOnc to the next level in its early days. Tim will remain on the team in an advisory capacity. We look forward to continuing our work together to build a better future for solid tumor patients.

SyzOnc's new website is live! Come visit us at www.syzonc.com. Many thanks to the team at OPTIO - Strategic Storytelling for creating this beautiful site for us.

We're excited to announce that SyzOnc was awarded the MIT-Royalty Pharma pitch competition grand prize! Our sincere thanks to all the mentors and organizers who made this program possible, and congratulations to all of the professors in our cohort! They're all doing brilliant work to make the world a better place :)

SyzOnc is thrilled to announce that we’ve opened our doors at B₊labs in Philadelphia. We’re ready to change the face of oncology with our first-in-class human-first, systems-level solution for cancer therapeutics discovery!